Calendrier des promotions Greenwich LifeSciences, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.| IPO date | 2020-09-25 |
|---|---|
| ISIN | US3968791083 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://greenwichlifesciences.com |
| Цена ао | 10.63 |
| Changement de prix par jour: | -5.17% (9.28) |
|---|---|
| Changement de prix par semaine: | -2.98% (9.07) |
| Changement de prix par mois: | -26.67% (12) |
| Changement de prix sur 3 mois: | -27.03% (12.06) |
| Changement de prix sur six mois: | -37.05% (13.98) |
| Changement de prix par an: | -38.29% (14.26) |
| Evolution du prix sur 3 ans: | -50.09% (17.63) |
| Evolution des prix depuis le début de l'année: | -29.71% (12.52) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Vanguard Group Inc | 221682 | 1.73 |
| Blackrock Inc. | 57148 | 0.44 |
| Ameriprise Financial, Inc. | 53647 | 0.42 |
| Geode Capital Management, LLC | 46816 | 0.36 |
| Renaissance Technologies, LLC | 36600 | 0.28 |
| Northern Trust Corporation | 20983 | 0.16 |
| 683 Capital Management LLC | 19604 | 0.15 |
| Qube Research & Technologies Ltd | 14714 | 0.11 |
| JANE STREET GROUP, LLC | 14005 | 0.11 |
| State Street Corporation | 13002 | 0.1 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. Snehal S. Patel | CEO, CFO & Director | 1.09M | 1964 (61 année) |
| Mr. Eric Rothe | Founder & Independent Director | 65.64k | 1976 (49 années) |
| Dr. Frank Joseph Daugherty M.D. | Chief Medical Officer & Director | N/A | 1951 (74 année) |
| Dr. Jaye L. Thompson Ph.D. | Vice President Clinical & Regulatory Affairs | N/A | 1966 (59 années) |
| Dr. Christine T. Fischette Ph.D. | VP of Business Development | N/A | 1951 (74 année) |
Adresse: United States, Stafford. TX, Building 14 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://greenwichlifesciences.com
Site web: https://greenwichlifesciences.com
